We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-5.16%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$10.8B
AUM Growth
-$966M
Cap. Flow
-$176M
Cap. Flow %
-1.63%
Top 10 Hldgs %
11.09%
Holding
1,042
New
69
Increased
438
Reduced
347
Closed
31

Top Buys

Rank Stock Value
1
POWL icon
Powell Industries
POWL
+$34.4M
2
FTAI icon
FTAI Aviation
FTAI
+$33M
3
CFG icon
Citizens Financial Group
CFG
+$32.4M
4
RTX icon
RTX Corp
RTX
+$28.1M
5
PAR icon
PAR Technology
PAR
+$26.3M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$155M
2
CYBR
CyberArk
CYBR
+$49.4M
3
UNH icon
UnitedHealth
UNH
+$33.5M
4
CMCO icon
Columbus McKinnon
CMCO
+$32.7M
5
CHX
ChampionX
CHX
+$29.6M

Sector Composition

Rank Sector Weight
1 Industrials 17.37%
2 Healthcare 16.24%
3 Technology 16.09%
4 Financials 15.05%
5 Consumer Discretionary 12.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOD icon
951
Vodafone
VOD
$37.2B
$3K ﹤0.01%
344
– –
AAL icon
952
American Airlines Group
AAL
$9.88B
$2K ﹤0.01%
153
-234
-60% -$3.52K
AEG icon
953
Aegon
AEG
$13.9B
$2K ﹤0.01%
281
-137
-33% -$876
ALLE icon
954
Allegion
ALLE
$14.1B
$2K ﹤0.01%
12
-1
-8% -$129
APA icon
955
APA Corp
APA
$14B
$2K ﹤0.01%
95
– –
DVA icon
956
DaVita
DVA
$11.6B
$2K ﹤0.01%
15
– –
EMN icon
957
Eastman Chemical
EMN
$8.29B
$2K ﹤0.01%
25
+6
+32% +$567
FMS icon
958
Fresenius Medical Care
FMS
$12.6B
$2K ﹤0.01%
70
– –
GRAB icon
959
Grab
GRAB
$14.7B
$2K ﹤0.01%
479
– –
HSIC icon
960
Henry Schein
HSIC
$10.1B
$2K ﹤0.01%
26
– –
ICL icon
961
ICL Group
ICL
$7.06B
$2K ﹤0.01%
314
– –
IVZ icon
962
Invesco
IVZ
$13.9B
$2K ﹤0.01%
112
-14
-11% -$239
JHX icon
963
James Hardie Industries
JHX
$17.9B
$2K ﹤0.01%
105
– –
JKHY icon
964
Jack Henry & Associates
JKHY
$10.8B
$2K ﹤0.01%
9
– –
LNT icon
965
Alliant Energy
LNT
$18.2B
$2K ﹤0.01%
27
– –
LOGI icon
966
Logitech
LOGI
$14.8B
$2K ﹤0.01%
28
– –
MNDY icon
967
monday.com
MNDY
$3.63B
$2K ﹤0.01%
8
– –
MT icon
968
ArcelorMittal
MT
$55.9B
$2K ﹤0.01%
78
– –
NI icon
969
NiSource
NI
$20.1B
$2K ﹤0.01%
54
– –
NICE icon
970
Nice
NICE
$5.78B
$2K ﹤0.01%
12
– –
PSO icon
971
Pearson
PSO
$9.7B
$2K ﹤0.01%
142
– –
SNN icon
972
Smith & Nephew
SNN
$12.5B
$2K ﹤0.01%
66
– –
STM icon
973
STMicroelectronics
STM
$48.4B
$2K ﹤0.01%
92
– –
TAP icon
974
Molson Coors Class B
TAP
$7.75B
$2K ﹤0.01%
30
-4
-12% -$230
TEAM icon
975
Atlassian
TEAM
$39.4B
$2K ﹤0.01%
9
– –
37 38
39
40 41

Similar funds

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

GW&K Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, GW&K Investment Management held 1,042 positions worth $10.8B, down 8.2% from $11.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q1 2025 filing shows 69 new, 438 increased, 347 reduced and 31 closed positions. Its largest new stake was Powell Industries: 492,876 shares worth $28M. The largest sale was Intra-Cellular Therapies Inc., an estimated $155M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • GW&K Investment Management's largest Q1 2025 buy was Powell Industries: 492,876 shares worth $28M.
  • GW&K Investment Management added most to Citizens Financial Group in Q1 2025, an estimated $32.4M increase.
  • GW&K Investment Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $155M.
  • GW&K Investment Management fully exited TriNet in Q1 2025, selling an estimated $12.7M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $10.8B portfolio in Q1 2025.
  • GW&K Investment Management opened 69 new positions and closed 31 in Q1 2025.
  • GW&K Investment Management's portfolio value fell 8.2% quarter-over-quarter to $10.8B.

Based on GW&K Investment Management's 13F filing for Q1 2025, filed 5 May 2025.